Funding Round Plant Science

BiocSol Secures €5.2M Seed Funding, Targeting €10M In Funding By Year-End

BiocSol announced the successful closure of its initial seed funding round, raising €5.2 million ($5.6 million) in equity.
Image provided by Biocsol.

Key Takeaways:

  • Successful Seed Round: BiocSol has raised €5.2 million ($5.6 million) in equity during its initial seed funding round.
  • Expanding Operations: Funds will support team expansion, R&D pipeline growth, regulatory processes for biofungicides, and increased production capacity.
  • Leading Investors: Agri Investment Fund and VIVES IUF led the round, with additional support from Belgian investors such as Invest.BW and IMBC Spinnova SA.
  • Innovative Technology: BiocSol develops microbial-based biopesticides addressing key agricultural challenges, including fungal and oomycete pathogens.
  • Future Goals: BiocSol aims to attract €10 million in total funding by year-end through additional non-dilutive and equity financing.

BiocSol, a UCLouvain spin-off specializing in sustainable crop protection solutions, has announced the successful closure of its initial seed funding round, raising €5.2 million ($5.6 million) in equity. This funding will enable the company to advance its mission of providing farmers with eco-friendly and efficient biopesticides for sustainable agriculture.

Investors and Strategic Impact

The funding round was co-led by Agri Investment Fund and VIVES IUF, two prominent investors with extensive expertise in agribusiness and biotechnology. Additional support came from Belgian investors, including Invest.BW and IMBC Spinnova SA. The funding will act as a catalyst for BiocSol’s development, supporting key initiatives such as:

  • Expanding the company’s team.
  • Broadening the research and development pipeline.
  • Advancing regulatory approvals for its pioneering biofungicides.
  • Scaling production to meet growing demand while enhancing quality and efficiency processes.

“We are thrilled by the confidence our investors have shown in our biopesticides technology and our long-term vision,” said Denis Payen, CEO of BiocSol. “With this funding, we can scale up our technology, providing farmers worldwide with access to more sustainable and efficient agricultural solutions. In the face of climate change and resource limitations, our microbial-based methods offer a future-forward, eco-friendly approach.”

Revolutionizing Biocontrol in Agriculture

BiocSol leverages microbial-based biopesticides to combat pathogens such as fungi and oomycetes, which threaten global food security by destroying between 20% and 40% of annual harvests. By harnessing specific microbial substances, BiocSol creates stable, cost-effective biosolutions to address critical agricultural challenges, such as combating mildew agents and improving crop resilience.

“This new investment is strategic for our fund as it enables us to become part of the rapidly growing Wallonia AgTech ecosystem,” said Patrik Haesen, CEO of Agri Investment Fund. “BiocSol’s innovative approach addresses some of the most pressing agricultural problems by creating multiple modes of action to combat pathogens that are rapidly developing resistance to current solutions.”

A Decade of Research at UCLouvain

Built on over 10 years of research at UCLouvain’s Earth & Life Institute, BiocSol has developed a unique molecular platform that opens new opportunities for sustainable, microbial-based crop protection. The company’s innovations have drawn praise from its academic and technological partners.

“Closing this seed round shows the quality and the potential of the research in applied microbiology conducted at the Earth and Life Institute of UCLouvain,” said Xavier Bastin, CEO of Sopartec SA, UCLouvain’s technology transfer company. “We are excited to see the BiocSol team further develop this technology to address the environmental challenges encountered by the agricultural sector.”

Building Toward Future Growth

BiocSol’s vision includes fostering global food security through innovative crop protection methods. The company plans to attract €10 million in total funding by year-end through additional non-dilutive and equity financing, enabling further advancements in its technology and market reach.

“This round is a significant achievement, especially in today’s challenging funding environment,” said Yannick Vancoppenolle, Partner at VIVES Partners. “We fully believe in BiocSol’s mission to create resilient agricultural solutions for current and future challenges.”

CEO and Founder Perspectives

BiocSol’s leadership emphasized the importance of this funding milestone in driving the company’s growth and impact.

  • Simon Caulier, CTO and founder of BiocSol: “We’re at a pivotal moment for the company, advancing our mission to develop sustainable crop protection solutions. This investment allows us to bring impactful solutions to agriculture, fostering a healthier planet for future generations.”
  • Denis Payen, CEO: “Scaling our technology is critical in providing farmers worldwide with tools to adopt sustainable and efficient agricultural practices.”

administrator
As a dedicated journalist and entrepreneur, I helm iGrow News, a pioneering media platform focused on the evolving landscape of Agriculture Technology. With a deep-seated passion for uncovering the latest developments and trends within the agtech sector, my mission is to deliver insightful, unbiased news and analysis. Through iGrow News, I aim to empower industry professionals, enthusiasts, and the broader public with knowledge and understanding of technological advancements that shape modern agriculture. You can follow me on LinkedIn & Twitter.

Leave a Reply